Nine Cheese Hall marketing reform or success or failure of OEM products are referred to exaggerated publicity

Zhu Wenda 2012, nine Zhi Tang (000989.SZ) net profit or decline 30%-50%, the company explained as the marketing model adjustment. Puzzled is, nine Zhi Tang at the end of 2011, put forward to promote expansion and other business reform ideas, and in the middle of 2012, but became the control of shipments. March 8, nine Zhi Tong, a staff member explained that the form of supply in the past is the first goods after the paragraph, and now to the first paragraph after the mode of goods, it led to the company's net profit decline. It is worth mentioning that nine Zhi Tang spent 45 million yuan invested in the establishment of nine Zhi Tang Peng Mao Company, operated by the United States L-Arabic sugar products for OEM products, the company introduced its hypoglycemic, slimming health function. The difference is that the product in Europe and the United States as a large number of food additives, and the Ministry of Health in the document described in the scope of use also for food. Net profit down 30%-50% marketing reform or success pen nine Zhi Tang is a listed company from Changsha, Hunan, mainly engaged in blood series, Tonic series, hepatitis series and other traditional Chinese medicine and the regulation of human immune biological agents production and sales, the current company's actual control for the Hunan Chung Gold Investment Co. January 11, nine cheese Hall released 2012 annual performance forecasts, the company's net profit is expected to be 100.89 million yuan-141.25 million yuan, down 30% to 50% from a year earlier. In 2011, nine Cheese Hall achieved a net profit of 202 million yuan, compared with 2010 163 million yuan increased by 24.03%. For 2012 years of sharp decline in performance, nine Cheese Hall in the announcement explained that the reason for the performance change is the company's 2012 marketing model adjustment, resulting in sales revenue and profit decline. For the marketing model adjustment, nine cheese Hall in 2012 said in the medium term, in order to give future sales growth to create good conditions, the company will sell the model to control marketing. In short, control shipments. In the 2011 report, nine Zhi Tang for the idea of marketing reform, to the Hunan market as a pilot, integration channels, the implementation of the one or two-level distribution, promote the national chain store on the Ark and promotion, from the rural market to the urban market expansion, the price of chaos, terminal maintenance of pharmacies to clean up and standardize. Some investors questioned, nine Tang in 2011, the marketing reform proposed in fact, and in 2012, why become the control of shipments, operating ideas inconsistent, whether to lead to a substantial decline in corporate performance the root cause? March 8, China Capital Securities network contact nine Zhi Tong Office, a staff explained that the past supply form is the first goods after the paragraph, and now to the first paragraph after the goods model. 45 million the effectiveness of the establishment of OEM products is insufficient? In fact, nine cheese to use its own technical advantages, into the health care industry, investment set up a subsidiary, but so far has not released the latest progress, attracted the attention of investors. April 17, 2012, nine Zhi Tang issued foreign Investment Bulletin, the company and the holding subsidiary of Hainan Nine Zhi Tong Pharmaceutical Co., Ltd., respectively, investment 45 million yuan, 5 million yuan, set up nine Zhi Tang Health Technology Co., Ltd. As of the middle of 2012, theThe investment subsidiary's pre-approved name is determined to be nine cheese Hall Peng Mao Technology Co., Ltd. (hereinafter referred to as nine Zhi Tang Peng Mao), is processing business registration. Through Hunan, Hainan, Beijing and other business departments to find out, nine Zhi Tang Peng Mao Company in Beijing on July 30, 2012, Incorporated. Data show that nine Zhi Tang Peng Mao Company sales of products for the United States L-Arab sugar, the main raw materials for L-Arabic sugar, and the product is not nine Zhi tang own intellectual property technology, is commissioned Tang Biotechnology (Xiamen) Co., Ltd. OEM production. At the same time, nine Zhi Tang Peng Mao Company in its website, said, Zhi Sheng Mei L-Arab has auxiliary hypoglycemic, slimming health function. It is worth mentioning that the Ministry of Health, in document 12th of 2008, stated that the molecular formula of L-Arabic sugar was c5h10o5, and the production process was obtained by dilute acid hydrolysis, decolorization, acid removal, bio-fermentation, separation, purification, crystallization and drying, with corn cob and corn peel as raw materials. A doctor with many years of clinical experience said that the English name of L-Arabic is l-arabinose, white powder, is a low-calorie sweetener, to some extent, can inhibit the absorption of sugar, in Europe and the United States as a large number of food additives, and can not rely on this to reduce blood sugar, weight loss. (Source: China Capital Securities Network)